Genome Editing Corrects Hemophilia in Animals
Published on in CHOP News
A CHOP study advances a genome editing, an innovative gene therapy technique, in which scientists treated the blood clotting disorder hemophilia in mice. Genome editing precisely targets and repairs a genetic defect.